Cargando…
Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation
Dengue virus (DENV) infection causes one of the most widespread mosquito-borne diseases in the world. Despite the great need, effective vaccines and practical antiviral therapies are still under development. Intracellular lipid levels are regulated by sterol regulatory elements-binding proteins (SRE...
Autores principales: | Uchida, Leo, Urata, Shuzo, Ulanday, Gianne Eduard L., Takamatsu, Yuki, Yasuda, Jiro, Morita, Kouichi, Hayasaka, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776201/ https://www.ncbi.nlm.nih.gov/pubmed/26875984 http://dx.doi.org/10.3390/v8020046 |
Ejemplares similares
-
Development and utility of an in vitro, fluorescence-based assay for the discovery of novel compounds against dengue 2 viral protease
por: Ulanday, Gianne Eduard L., et al.
Publicado: (2016) -
SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth
por: Wang, Tong-bing, et al.
Publicado: (2021) -
PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum
por: Machado, Patrícia de Almeida, et al.
Publicado: (2021) -
Pathogenic potential and growth kinetics of Muko virus in mice and human-derived cells
por: Ulanday, Gianne Eduard L., et al.
Publicado: (2016) -
Subtilisin of Leishmania amazonensis as Potential Druggable Target: Subcellular Localization, In Vitro Leishmanicidal Activity and Molecular Docking of PF-429242, a Subtilisin Inhibitor
por: Gomes, Pollyanna Stephanie, et al.
Publicado: (2022)